Denali Therapeutics Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets↓-16.7% -$229M
$1.14B
Current Assets↑+4.2% +$36M
$901M
Cash & Equivalents↑+17.4% +$30M
$205M
ST Investments↑+0.8% +$5M
$663M
Receivables
—
Net PPE↓-5.1% -$3M
$52M
Total Liabilities↓-9.3% -$13M
$131M
Current Liabilities↓-3.8% -$4M
$98M
Account Payables↓-70.1% -$8M
$3M
Stockholders Equity↓-17.6% -$216M
$1.01B
Retained Earnings↓-33.3% -$513M
$-2.05B
Operating Lease ROU Asset↓-16.9% -$4M
$19M
Operating Lease Liability↑+0.0% +$0
$37M
Finance Lease ROU Asset↑+2.1% +$998K
$49M
Gross PP&E↑+7.5% +$8M
$115M
Accumulated Depreciation↑+20.9% +$11M
$63M
Contract Liability
—
Contract Liability (Current)
—
Contract Liability (Noncurrent)
—
Remaining Performance Obligation
$0